Frontlight ResearchEarly access
Endometriosis trials in China
7 of 13 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis
- Where
- Changsha, Suzhou
- Age
- 18 years to 45 years
- People
- 20
- Run by
- Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07755956 - No phaseTaking peopleStellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery
- Where
- Huai'an
- Age
- 18 years to 75 years
- People
- 100
- Run by
- Catherin Zhang
See details and how to joinNCT07860203 - Phase 3Taking peopleEvaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain
- Where
- Beijing, Nanning, Shanghai, Suzhu, Tianjin
- Age
- 18 years to 49 years
- People
- 540
- Run by
- Hope Medicine (Nanjing) Co., Ltd
See details and how to joinNCT07318688 - Phase 4Taking peopleUltra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis
- Where
- Nanjing
- Age
- 18 years to 39 years
- People
- 120
- Run by
- Li-jun Ding
See details and how to joinNCT07696351 - No phaseTaking peopleEfficacy and Safety of Intra-operative Dual Laparoscopy and Neo-rectoscopy for Bowel Endometriosis: The LUMEN-01 Trial
- Where
- Shanghai
- Age
- 18 years to 55 years
- People
- 192
- Run by
- Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT07523308 - No phaseTaking peopleHerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women
- Where
- Hong Kong
- Age
- 18 years to 49 years
- People
- 100
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07006987 - Phase 2Taking peopleA Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
- Where
- Beijing
- Age
- 18 years to 49 years
- People
- 200
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06963177